Brief: Logicbio Therapeutics Reports Q3 Financial Results, Provides Business Updates
14/11/2022 18:22
Nov 14 (Reuters) - Logicbio Therapeutics Inc LOGC.O :
* LOGICBIO THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATES
* NET LOSS FOR QUARTER ENDED SEPTEMBER 30, 2022, WAS $5.8
MILLION
OR $0.18 PER SHARE
* Q3 EARNINGS PER SHARE VIEW $-0.21 -- REFINITIV IBES DATA
Source text for Eikon: ID:nPn481pTza
Further company coverage: LOGC.O
Recent news on ContextLogic Holdings
See all newsContextLogic Holdings Q2 revenue flat as higher prices offset lower volumes
Brief: ContextLogic Holdings Q2 Adjusted EBITDA USD 10.8 Million
ContextLogic Holdings Q1 net income jumps on tax benefit
Brief: ContextLogic Holdings Q1 Net Income USD 17 Million
Brief: Contextlogic To Acquire US Salt From Emerald Lake In $907.5 Million Transaction, Creating New Business Ownership Platform In Partnership With Abrams Capital And BC Partners Credit